Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 185
Filter
1.
New Cardiovascular Disease Risk Calculator Could Eliminate the Need for Statins for Millions.
Larkin, Howard.
JAMA ; 332(3): 186-187, 2024 07 16.
Article in English | MEDLINE | ID: mdl-38904970

ABSTRACT

This Medical News article discusses a recent study in JAMA Internal Medicine that estimated statin eligibility using the new PREVENT equations compared with the older equations.


Subject(s)
Cardiovascular Diseases , Hydroxymethylglutaryl-CoA Reductase Inhibitors , Humans , Cardiovascular Diseases/prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Risk Assessment , United States , Heart Disease Risk Factors
2.
What to Know About PREVENT, the AHA's New Cardiovascular Disease Risk Calculator.
Larkin, Howard.
JAMA ; 331(4): 277-279, 2024 01 23.
Article in English | MEDLINE | ID: mdl-38150239

ABSTRACT

This Medical News article discusses the American Heart Association's new cardiovascular disease risk calculator, called PREVENT.


Subject(s)
Cardiovascular Diseases , Heart Disease Risk Factors , Risk Assessment , Humans , American Heart Association , Cardiovascular Diseases/prevention & control , United States
3.
Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.
Larkin, Howard.
JAMA ; 330(21): 2042-2043, 2023 12 05.
Article in English | MEDLINE | ID: mdl-37938824

ABSTRACT

This Medical News article discusses a recent American Heart Association presidential advisory on CKM syndrome that lays the groundwork for a new cardiovascular disease risk calculator.


Subject(s)
Cardiovascular Diseases , Kidney Diseases , Metabolic Syndrome , Humans , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Cardiovascular System , Heart , Kidney , Metabolic Syndrome/diagnosis , Metabolic Syndrome/epidemiology , United States/epidemiology , Kidney Diseases/diagnosis , Kidney Diseases/epidemiology
4.
Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723971

Subject(s)
Adaptive Immunity , COVID-19 , Humans , Adaptive Immunity/immunology , Antibodies, Viral/immunology , COVID-19/immunology , COVID-19/prevention & control , SARS-CoV-2 , COVID-19 Vaccines/immunology , COVID-19 Vaccines/therapeutic use , Reinfection/immunology , Reinfection/prevention & control , Vaccination
5.
High COVID-19 Rates Prompt Call for Better Nursing Home Protections.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723972

Subject(s)
COVID-19 , Infection Control , Nursing Homes , Humans , COVID-19/epidemiology , Nursing Homes/standards , Nursing Homes/statistics & numerical data , Skilled Nursing Facilities/standards , Skilled Nursing Facilities/statistics & numerical data , Infection Control/methods , Infection Control/standards , Infection Control/statistics & numerical data
6.
Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target.
Larkin, Howard.
JAMA ; 329(7): 532, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723975

Subject(s)
COVID-19 Drug Treatment , COVID-19 , Humans , COVID-19/therapy , Risk Factors , SARS-CoV-2 , Host-Pathogen Interactions
7.
Vasopressors or High-Volume IV Fluids Both Effective for Sepsis.
Larkin, Howard.
JAMA ; 329(7): 532, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723977

Subject(s)
Fluid Therapy , Sepsis , Vasoconstrictor Agents , Humans , Fluid Therapy/methods , Sepsis/drug therapy , Sepsis/therapy , Shock, Septic/drug therapy , Shock, Septic/therapy , Vasoconstrictor Agents/therapeutic use
8.
National Academies: Expand US Wastewater Disease Surveillance.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723984

Subject(s)
COVID-19 , SARS-CoV-2 , Wastewater-Based Epidemiological Monitoring , Wastewater , Humans , Academies and Institutes , COVID-19/prevention & control , COVID-19/virology , RNA, Viral/isolation & purification , SARS-CoV-2/isolation & purification , Wastewater/virology , United States
9.
Agent Slows Glioblastoma Tumors in Mice by Blocking Fat Metabolism.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723985

Subject(s)
Antimetabolites, Antineoplastic , Brain Neoplasms , Glioblastoma , Lipid Regulating Agents , Animals , Mice , Brain Neoplasms/drug therapy , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Glioblastoma/drug therapy , Glioblastoma/metabolism , Glioblastoma/pathology , Lipid Regulating Agents/therapeutic use , Antimetabolites, Antineoplastic/therapeutic use
10.
Both High- and Low-Dose Exercise Therapy Help Knee Osteoarthritis.
Larkin, Howard.
JAMA ; 329(7): 532, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723986

Subject(s)
Exercise Therapy , Osteoarthritis, Knee , Humans , Exercise Therapy/methods , Osteoarthritis, Knee/therapy , Pain Measurement
11.
New Report on Mpox Cases Leading Up to 2022 Global Outbreak.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723992
12.
Nearly 500 000 in UK May Have Missed Blood Pressure Drugs.
Larkin, Howard.
JAMA ; 329(7): 531-532, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723993

Subject(s)
Antihypertensive Agents , Hypertension , Treatment Adherence and Compliance , Humans , Antihypertensive Agents/therapeutic use , Blood Pressure , Hypertension/drug therapy , Hypertension/epidemiology , United Kingdom/epidemiology , Treatment Adherence and Compliance/statistics & numerical data
13.
Combined COVID-19 and Flu Test Authorized for Point-of-Care Use.
Larkin, Howard.
JAMA ; 329(1): 14-15, 2023 01 03.
Article in English | MEDLINE | ID: mdl-36594962

Subject(s)
COVID-19 , Influenza, Human , Point-of-Care Systems , Humans , COVID-19/diagnosis , Influenza, Human/diagnosis , SARS-CoV-2
14.
First FDA-Approved Gene Therapy for Hemophilia.
Larkin, Howard.
JAMA ; 329(1): 14, 2023 01 03.
Article in English | MEDLINE | ID: mdl-36594963

Subject(s)
Genetic Therapy , Hemophilia A , Humans , Genetic Vectors , Hemophilia A/genetics , Hemophilia A/therapy
15.
New Drug Delays Type 1 Diabetes Onset.
Larkin, Howard.
JAMA ; 329(1): 14, 2023 01 03.
Article in English | MEDLINE | ID: mdl-36594964

Subject(s)
Diabetes Mellitus, Type 1 , Hypoglycemic Agents , Humans , Blood Glucose , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/prevention & control , Hypoglycemic Agents/therapeutic use
16.
Ceasefire Declared, but Ethiopian Health Systems Remain in Critical Condition After Civil War.
Larkin, Howard D.
JAMA ; 329(6): 451-453, 2023 02 14.
Article in English | MEDLINE | ID: mdl-36696152

ABSTRACT

This Medical News article discusses the total collapse of health care systems in Ethiopia during a 2-year armed conflict.


Subject(s)
Genital Neoplasms, Female , Humans , Female , Ethiopia , Warfare
17.
Whole-Sporozoite Malaria Vaccine Candidate Shows Real-world Promise.
Larkin, Howard.
JAMA ; 329(2): 115, 2023 01 10.
Article in English | MEDLINE | ID: mdl-36625824

Subject(s)
Malaria Vaccines , Malaria , Plasmodium falciparum , Sporozoites , Animals , Humans , Malaria/prevention & control , Malaria Vaccines/therapeutic use , Malaria, Falciparum/prevention & control
18.
Noninvasive Sensory Stimulation With Light and Sound Tested in Alzheimer Disease.
Larkin, Howard.
JAMA ; 329(2): 114, 2023 01 10.
Article in English | MEDLINE | ID: mdl-36625825

Subject(s)
Acoustic Stimulation , Alzheimer Disease , Photic Stimulation , Humans , Acoustic Stimulation/methods , Alzheimer Disease/diagnosis , Alzheimer Disease/therapy , Sound , Photic Stimulation/methods , Light
19.
Twenty-Strain "Universal" mRNA Flu Vaccine Effective in Animal Studies.
Larkin, Howard; Larkin, Howard.
JAMA ; 329(2): 114, 2023 01 10.
Article in English | MEDLINE | ID: mdl-36625826

Subject(s)
Influenza A virus , Influenza Vaccines , Influenza, Human , mRNA Vaccines , Animals , Humans , Influenza Vaccines/genetics , Influenza Vaccines/therapeutic use , Influenza, Human/genetics , Influenza, Human/prevention & control , Influenza, Human/virology , Vaccination , Influenza A virus/genetics , Vaccine Efficacy , mRNA Vaccines/genetics , mRNA Vaccines/therapeutic use
20.
More Adolescents and Young Adults Developing Type 2 Diabetes Around the World.
Larkin, Howard.
JAMA ; 329(3): 200, 2023 01 17.
Article in English | MEDLINE | ID: mdl-36648458

Subject(s)
Diabetes Mellitus, Type 1 , Diabetes Mellitus, Type 2 , Global Health , Adolescent , Humans , Young Adult , Diabetes Mellitus, Type 2/epidemiology , Risk Factors , Global Health/statistics & numerical data , Adolescent Health/statistics & numerical data
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL